Search

Background: Antiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia ® ). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transdermal administration might be an efficient alternative. The aim of this study was to demonstrate the antiemetic effect of maropitant administered via the transdermal route in cats., Case Description: There were 8 cats enrolled in this study, weighing between 2 and 7 kg, more than 6 months old, and experiencing at least 2 episodes of vomiting in the last 72 hours. Compounded transdermal maropitant was prepared using finely ground Cerenia ® tablets, dissolved in propylene glycol and incorporated in the commercial liposomal base Pentravan ® (Fagron ® , Thiais, France). The uniformity of content was determined using the high performance liquid chromatography (HPLC) method. The product was administered at a dosage of 4 mg/cat once a day (QD), applied on the inner pinna of the ear for five consecutive days. Monitoring and evaluation of vomiting frequency and nausea were performed. A significant decrease in vomiting frequency was observed in 6 of the 8 enrolled cats. A reduction in nausea, associated with an improvement of appetite, was observed in some cases., Conclusion: Transdermal application of maropitant to cats experiencing vomiting seems to be efficient and a good alternative to existing oral medication, taking into account the difficulty of oral administration in these cases. This work provides preliminary clinical results of the efficacy of transdermal maropitant in cats. Further studies are necessary to determine dosing and pharmacokinetics., Competing Interests: The authors declare that there is no conflict of interest.